Arrivent Biopharma Inc (AVBP)

Financing Cash Flow

$262.15M

TTM · Period ending: · USD

AVBP logo

AVBP Financing Cash Flow

Latest reported$262.15M
AVBP TTM Cash from Financing ($154.67M → $262.15M)
High-resolution chart · PNG

AVBP financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arrivent Biopharma Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
262,151,000
251,177,000
203,063,000
168,393,000
82,459,000
7,708,000
186,581,000
185,469,000
183,905,000
183,522,000
42,859,000
153,637,000
154,670,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.